Prota Therapeutics Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $7.43M
Latest Deal Amount
  • Investors
  • 2

Prota Therapeutics General Information

Description

Developer of immunotherapy-based treatment designed to treat peanut allergy in children. The company's treatment is developing the cure for the most common cause of life-threatening anaphylaxis (peanut allergy), enabling patients to get an effective cure from food allergies and lead a healthy life thereby.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • C/o FB Rice Reception
  • Level 33, 477 Collins Street
  • Melbourne, Victoria 3000
  • Australia
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Prota Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 06-Jun-2017 $7.43M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jan-2016 000.00 000.00 Completed Startup
To view Prota Therapeutics’s complete valuation and funding history, request access »

Prota Therapeutics Executive Team (4)

Name Title Board Seat Contact Info
Mimi Tang Founder, Acting Chief Executive Officer, Chief Medical & Scientific Officer
Cameron Jones Chief Financial Officer
You’re viewing 2 of 4 executive team members. Get the full list »

Prota Therapeutics Board Members (5)

Name Representing Role Since
Graeme Wald Ph.D OneVentures Co-Chairman 000 0000
Kelly Constable Self Board Member 000 0000
Paul Kelly MD Self Co-Chairman 000 0000
Shari Lofthouse Ph.D Self Board Member 000 0000
Tracey Brown Prota Therapeutics Board Member 000 0000
To view Prota Therapeutics’s complete board members history, request access »

Prota Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Australian Government Government Minority 000 0000 000000 0
OneVentures Venture Capital Minority 000 0000 000000 0
To view Prota Therapeutics’s complete investors history, request access »